Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300181.SZ

STRONG BUY

Zhejiang Jolly Pharmaceutical Co.,LTD · Healthcare · China · $1.3B · Avg Vol: $26M/d

85
StockRank
Get insider-trade alerts
Q
78
V
61
M
40
P/E (TTM)
14.4x
ROE
19.8%
D/E
0.2x
Dividend %
2.6%
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Zhejiang Jolly Pharmaceutical Co., Ltd. specializes in the research, development, and production of traditional Chinese medicine (TCM) preparations, with a core focus on medicinal fungi. Its flagship product, Wuling Capsule, is a market-leading TCM treatment for insomnia and anxiety, derived from proprietary fermentation technology of rare fungi. The company's competitive moat lies in its exclusive biological fermentation patents, strong clinical endorsement, and dominant market share in the neuro-psychiatric TCM segment.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue265.9M286.1M379.7M447.8M19.0%458.7M549.1M647.0M20.2%
EPS0.070.080.110.1426.9%0.140.150.1917.7%
Shares701.4M701.4M701.4M701.4M0.0%701.4M———
Debt25.5M32.7M63.3M101.9M58.7%112.9M———
Equity398.2M401.9M407.8M468.4M5.6%————
Op CF46.9M42.5M43.7M60.7M8.9%83.8M———
Inv CF-16.7M-38.8M-16.2M-60.6M—————
Fin CF94.7M-23.5M-50.0M-17.3M—————
Loading 1Y...
PRICE (1Y)-3.2%
1.881.942.002.062.11May 29Jun 22Jul 10
SMA 50SMA 200
Close
$1.98
RSI (14)
56.3
52W High
$3.03
From 52W High
0.7%

SCORE BREAKDOWN

Quality
78
ROIC
22.8%93.1
ROE
19.8%88.3
GP/Assets
41.1%80.8
Op. Margin
27.2%89.8
FCF/Assets
8.9%83.3
Piotroski
667.3
Int. Cover
50.0x88.5
D/E Ratio
0.22x51.1
Current Ratio
1.55x27.3
Value
61
P/E (TTM)
14.4x76.2
EV/EBITDA
10.9x64.0
P/FCF
21.6x54.0
P/B
2.7x47.9
P/S
3.0x56.1
Div Yield
2.6%59.5
Momentum
40
52W High %
65%43.8
RS 6M
-19%47.1
SMA 50/200
0.87x31.6
EPS Rev 4W
-0.3%36.9
EPS Rev 12W
—N/A
EPS Improve
+2%21.5
Q Growth
10%52.3

FUNDAMENTALS

Market Cap
$1.3B
P/E (Forward)
14.1x
Gross Margin
62.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300181.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
300181.SZZhejiang Jolly Pharmaceutical Co.,LTD(you)$1.3B85STRONG BUY
000411.SZZhejiang Int'l Group Co.,Ltd.$749M83STRONG BUY
600713.SSNanjing Pharmaceutical Group Company Limited$977M77BUY
688710.SSShanghai InnoStar Bio-tech Co., Ltd.$1.3B62HOLD
1666.HKTong Ren Tang Technologies Co. Ltd.$511M94STRONG BUY
300357.SZZhejiang Wolwo Bio-Pharmaceutical Co., Ltd.$1.6B61HOLD
600771.SSGuangYuYuan Chinese Herbal Medicine Co., Ltd.$916M48HOLD
1093.HKCSPC Pharmaceutical Group Limited$9.7B74BUY
002019.SZYifan Pharmaceutical Co., Ltd.$1.7B38HOLD
301507.SZHangzhou Minsheng Healthcare Co., Ltd.$633M44HOLD

Peer medians: ROE 4.7% · P/E 28.4x · Gross margin 52.5%

Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) — Stock Score Summary

Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) has a MoatMap StockRank of 85/100 based on Quality (78/100), Value (61/100), and Momentum (40/100) factor scores. The current signal is STRONG BUY.

Zhejiang Jolly Pharmaceutical Co., Ltd. specializes in the research, development, and production of traditional Chinese medicine (TCM) preparations, with a core focus on medicinal fungi. Its flagship product, Wuling Capsule, is a market-leading TCM treatment for insomnia and anxiety, derived from proprietary fermentation technology of rare fungi. The company's competitive moat lies in its exclusive biological fermentation patents, strong clinical endorsement, and dominant market share in the neuro-psychiatric TCM segment.

Key Financial Metrics

Price$1.98
Market Cap$1.3B
P/E (TTM)14.37
P/E (Forward)14.07
Price/Book2.73
Return on Equity19.8%
Return on Invested Capital22.8%
Debt/Equity21.94
Gross Margin62.1%
Operating Margin27.2%
Revenue Growth8.9%
Dividend Yield2.6%
Free Cash Flow$62M

Zhejiang Jolly Pharmaceutical Co.,LTD operates in the Drug Manufacturers - General industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Jolly Pharmaceutical Co.,LTD’s (300181.SZ) StockRank?
MoatMap’s StockRank for Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) is 85/100, with a Strong Buy signal. It is a composite of Quality (78), Value (61), and Momentum (40) factor ranks across MoatMap’s 20,000+ stock universe.
Does Zhejiang Jolly Pharmaceutical Co.,LTD have an economic moat?
Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) has a Quality factor score of 78/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Jolly Pharmaceutical Co.,LTD a buy, hold, or sell?
MoatMap’s current signal for Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) is Strong Buy, based on a StockRank of 85/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Jolly Pharmaceutical Co.,LTD in?
Zhejiang Jolly Pharmaceutical Co.,LTD (300181.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (China).
Browse all ranked stocks300181.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock